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Abstract 
Mesenchymal stem cells (MSCs) are multipotent precursor cells originating from several 
adult connective tissues. MSCs possess the ability to self-renew and differentiate into several 
lineages, and are recognized by the expression of uique cell surface markers. Several lines 
of evidence suggest that various signal transduction pathways and their interplay regulate 
MSC differentiation. To that end, a critical player in regulating MSC differentiation is a 
group of proteins encoded by the Wnt gene family, which was previously known for 
influencing various stages of embryonic development and cell fate determination. As MSCs 
have gained significant clinical attention for their potential applications in regenerative 
medicine, it is imperative to unravel the mechanisms by which molecular regulators control 
differentiation of MSCs for designing cell-based therapeutics. It is rather coincidental that the 
functional outcome(s) of Wnt-induced signals share similarities with cellular redox-mediated 
networks from the standpoint of MSC biology. Furthemore, there is evidence for a crosstalk 
between Wnt and redox signalling, which begs the question whether Wnt-mediated 
differentiation signals involve the intermediary role f reactive oxygen species. In this 
review, we summarize the impact of Wnt signalling o multi-lineage differentiation of MSCs, 
and attempt to unravel the intricate interplay between Wnt and redox signals. 
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Introduction 
Clinical significance of mesenchymal stem cells and their differentiation 
There has been a recent surge in interest in the clinical use of mesenchymal stem cells 
(MSCs) in regenerative medicine, tissue repair, and other cell-based therapies [1]. MSCs 
have been isolated from various sources such as bone marrow [2], adipose tissue [3], 
umbilical cord tissue [4], periodontal ligament [5], synovial membrane [6], menstrual fluid 
[7], and dental pulp [8]. Although bone marrow was the earliest identified source of MSCs 
[9], the utility of marrow-derived MSCs was limited due to several factors such as invasive 
surgery and subsequent patient discomfort. Hence, sources of MSCs other than the bone 
marrow, such as described above, have been aggressively explored in recent years. 
MSCs are capable of extensive self-renewal in an undifferentiated state, but upon appropriate 
and specific stimuli are capable of multi-potent differentiation towards various cell lineages. 
Although the preference is for differentiation to mesenchymal lineages, there is strong 
experimental evidence for differentiation to all three germ layers - mesoderm, ectoderm, and 
endoderm [5, 10-13]. As such, a better understanding of the process of MSC differentiation at 
the molecular level is essential if MSCs are to achieve the potential for their application in 
regenerative medicine. This demands an understanding of the signal transduction pathways 
regulating MSC differentiation, amongst which Wnt signalling is one of the key players. 
Hence, in this review, we highlight how the Wnt signalling network impacts MSCs and 
influences their fate. Our primary focus will be the interaction between the canonical Wnt 
signalling pathway and MSC differentiation. Further, we will describe the effect of reactive 
oxygen species (ROS) on MSC differentiation and the crosstalk between ROS and Wnt to 
influence MSC differentiation. 
1.2. Wnt signalling 
Wnt signalling is evolutionarily conserved from nematodes to mammals, regulating various 
stages of embryonic development as well as tissue homeostasis in adulthood [14, 15]. Wnt 
signalling affects major cellular events such as proliferation, survival, apoptosis, angiogenesis 
and cell polarity. It is also involved in regulating self-renewal and differentiation of stem 
cells in adult tissues, and regulating the regenerativ  processes in response to disease, trauma, 
and ageing. The Wnt molecules are secreted glycoproteins composed of 350-400 amino acid 
residues, of which 23-24 are highly conserved cysteine residues (molecular weight: 39kDa-
46kDa) [14]. The difference in mode of signalling sub equent to the generation of the Wnt 
signal classifies the Wnt signalling network into two main branches, depending on the 
intracellular response it triggers. One is the canonical pathway mediated by β-catenin, while 
another is the non-canonical signalling pathway that involves protein kinase C (PKC) and c-
jun N-terminal kinases (JNK). 
 
1.2.1. Canonical Wnt signalling 
The canonical Wnt signalling pathway is β-catenin mediated. Here, the Wnt ligand forms a 
ternary complex with a Frizzled (Fz) receptor and low-density lipoprotein receptor-related 
protein 5/6 (LRP5/6) co-receptor to activate the intracellular Dishevelled (Dvl) protein. Dvl 
in turn phosphorylates and inhibits glycogen synthase kinase-3β (GSK-3β) of the destruction 
complex. The destruction complex is composed of the proteins, axin, adenomatous polyposis 













coli (APC), casein kinase 1α (CK1α), and GSK-3β, and is responsible for the phosphorylation 
and subsequent degradation of β-catenin in the absence of Wnt signalling. In the pr sence of 
a Wnt stimulus the complex remains inactive, leading to accumulation of the 
unphosphorylated β-catenin in the cytoplasm and consequent translocation to the nucleus. In 
the nucleus, β-catenin replaces the co-repressors and binds to the transcriptional factor 
complex composed of T cell factor/Lymphoid-enhancing factor (TCF/LEF), thereby 
triggering the transcription of the Wnt target genes. 
 
1.2.2. Non-canonical Wnt signalling 
Non-canonical Wnt signalling is independent of β-catenin and involves several distinct 
pathways. One of the non-canonical pathways impacts on cell migration by regulating the 
activation of Calcium/calmodulin-dependent protein ki ase II (CaMKII) and protein kinase C 
(PKC), thereby resulting in the release of intracellular calcium [16, 17]. This association with 
cellular Ca2+ mobilization has led to the description ‘Wnt/Ca2+ signalling pathway’. A 
second, non-canonical pathway controlling cell polarity and cytoskeletal organization is 
referred to as the Wnt/planar cell polarity (PCP) signalling pathway. It acts by activating 
Rho-GTPases and Jun N-terminal kinases (JNKs) [16, 17]. The molecular events occurring in 
these non-canonical pathways are generally less well defined than the canonical pathway. 
 
1.2.3. Regulators of the Wnt signalling pathway 
Among the various molecules that modulate the Wnt signalling pathway [18] are extracellular 
Wnt antagonists such as secreted Frizzled-related proteins (sFRPs), Dickkopfs (Dkks), and 
Wnt Inhibitory Factor1 (WIF1) [19, 20]. Briefly, sFRPs are the first identified secreted 
antagonists of the canonical and non-canonical Wnt sig alling pathways and, in humans, they 
are 5 in number (sFRP1-5) [20-24]. Among them, the major Wnt antagonist sFRP4 was first 
isolated by our group by the use of a rat cDNA library [21]. By inactivating Wnt, sFRPs 
prevent the accumulation of active unphosphorylated β-catenin in the cytoplasm, thereby 
suppressing the activity of Wnt target genes [19, 25].
The Fz receptors possess an extracellular cysteine-rich domain (CRD) composed of 120 
amino acids [15], which shares structural homology to the CRD in the N-terminal region of 
sFRPs [26]; sFRPs lack the transmembrane domain present in Fz receptors. sFRP anatgonizes 
Wnt signalling by interfering with the Wnt-Fz interaction through direct binding to the Wnt 
or to the Fz receptor, thereby forming a non-functional complex. While the latter mechanism 
(sFRP-Fz binding) is facilitated by the CRD of the sFRPs [27], the former mechanism (sFRP-
Wnt binding) can occur either via the CRD [28] or the domains in the C-terminal region of 
sFRPs [29]. In addition, the biphasic regulatory potential of sFRPs has been elucidated by 
evidence of Wnt binding to the CRD in the N-terminal region of sFRPs and inhibiting β-
catenin accumulation; while Wnt binding to the domain in the C-terminal region of sFRP 
allows the CRD at the N-terminus to interact with Fz, hence facilitating Wnt signalling [29]. 
Other Wnt anatagonists such as the Dickkopf (Dkk) family includes 4 members (Dkk 1-4), 
which inhibit only the canonical Wnt signalling by inding to the LRP5/6 co-receptor [19]. In 
addition to these naturally occurring extracellular Wnt antagonists, there are 
pharmacologically derived antagonists such as XAV939 [23] and iCRT3 [24]. In this review 
we focus on how these different Wnt regulators play a role in Wnt signal transduction and 
influence the cell fate determination of MSCs. 
 
2. Role of Wnt signalling pathways in differentiation of mesenchymal stem cells 
2.1. Role of Wnt signalling in adipogenic differentiation 
Evidence from the last decade indicates an important ole for Wnt signalling in adipogenic 
differentiation from precursor cells. [30]. An inhibitory effect on adipogenesis by Wnt-













activating molecules such as Wnt 10b, GSK-3β inhibitors such as lithium chloride (LiCl) 
[31], and CHIR 99021 [32] has been demonstrated using 3T3 pre-adipocytes. Wnt4 and 
Wnt5a, both non-canonical Wnt ligands, have been shown to possess a promoting effect on 
3T3 cell adipogenesis through the PKC-CamKII pathway. Additionally, the authors refer to 
antagonism of the canonical Wnt signalling pathway by Wnt5a [33]. 
In MSCs, the inhibitory effect on adipogenesis has been demonstrated using the GSK-3β 
inhibitor (Wnt activator) - 6-bromo-indirubin-3’-oxime (BIO) [34]. Wnt activation (by 
silencing the Wnt antagonists sFRP4 and Dkk1) was performed in adipose MSCs, which 
resulted in significant down-regulation of adipogenic differentiation with regard to lipid 
accumulation as well as adipogenic markers [35]. It has also been reported that a short 48 
hour treatment with sFRP1 and sFRP4 upregulated adiponectin secretion in human MSCs 
[36]. 
Additionally, during adipogenic differentiation of MSCs, the levels of the Wnt antagonists 
sFRP4 and Dkk1 were seen to be higher than in the undifferentiated state [35]. Our laboratory 
has demonstrated that addition of exogenous sFRP4 promoted adipogenic differentiation of 
MSCs [37]. This in vitro evidence indicates the presence and significance of the suppressed 
state of Wnt signalling during adipogenesis. The importance of Wnt antagonist levels has 
been teased out by a few clinical studies. In one of them, sFRP4 levels were seen to be 
directly proportional to impaired glucose and triglyceride metabolism [38], and in another 
study sFRP4 was proposed as a biomarker for predicting type II diabetes mellitus [39]. 
Overall, the activation of the Wnt signalling pathway inhibits adipogenic differentiation in 
MSCs, while the presence of Wnt antagonists promotes a contrary effect on adipogenesis, 
which could be considered when developing new strategies to manage obesity and diabetes. 
 
2.2. Wnt signalling regulates osteogenic differentiation 
Growing evidence suggests a regulatory role for Wntsignalling in bone development and 
homeostasis. In MSCs, the in vitro potential of Wnt signalling on osteogenic differentiation 
has been controversial, with both stimulatory and inhibitory effects being reported. It has 
been shown that the canonical Wnt signalling pathway activates differentiation of MSCs into 
osteoblasts [40]. The disruption of Wnt signalling by a functional mutation or targeted 
destruction of LRP5 in mice has been shown to promote osteoporosis and a low bone mass 
phenotype [41, 42], while its over-expression leads to a high bone mass syndrome [43]. In 
another study, the supportive role of Wnt proteins towards osteogenesis was shown by 
preventing apoptosis of osteoblast progenitors and differentiated osteoblasts in the osteoblast 
cell line OB-6 and pre-osteoblast cell line MC3T3-E1 [44]. The Wnt ligand Wnt10b was 
shown to prevent bone loss occurring due to oestrogen deficiency and aging in mice [45]. It 
was reported that Wnt signalling favoured osteogenesis at the expense of adipogenesis [46, 
47]. It was also demonstrated that suppression of PPARγ and C/EBPα, and the simultaneous 
enhancement of the expression of osteoblastogenic transcription factors such as RunX2, 
Dlx5, and Osterix occurred in mouse mesenchymal cells [45, 46]. 
With regard to the effect of Wnt antagonism on ostegenesis, it has been reported to be 
mostly inhibitory. In mice over-expressing the Wnt a tagonist sFRP4 in osteoblasts, there 
was a reduction observed in bone formation, leading to a low bone mass [48]. This inhibitory 
effect of Wnt antagonists on osteogenesis was also demonstrated by an i vitro study where 
sFRP4 inhibited osteogenic differentiation in MSCs from periodontal tissue [49]. Among 
other Wnt antagonists, sFRP1 over-expression was found to also inhibit in vivo bone 
formation [50] and increase the rate of osteoblast and osteocyte cell death [48]. The lack of 
sFRP1 reduced apoptosis and accelerated osteoblast proliferation and differentiation in 
human osteoblasts and MSCs [51], and also enhanced trabecular bone formation and 













improved fracture healing [51-53], indicating the inhibitory effect of Wnt antagonists on 
osteogenesis. 
Many other signalling pathways, such as the Hippo signalling pathway, interact with Wnt. 
Hippo signalling involves Yes-associated protein 1 (YAP1), which upregulates Dkk1 and, in 
turn, supresses canonical Wnt signalling to inhibit the osteogenic potential of MSCs [54]. The 
stimulatory effect of Wnt has been shown in human MSCs [55] and also in mouse MSCs 
[56], where an increased expression of the osteogenic transcription factor RunX2 was 
observed [56]. Overall, these studies indicate that canonical Wnt activation promotes 
osteogenesis, while Wnt antagonists inhibit osteogenesis from MSCs. 
Other studies have reported an inhibition of osteogenesis by the canonical Wnt pathway in 
human bone marrow MSCs [57-59]. One group reported that sFRP3 promoted osteoblast 
differentiation [60]. A recent study explained this phenomenon in further detail by showing 
that sFRP3 antagonises the non-canonical Wnt pathway through Wnt5a binding, which in 
turn blocks Wnt5a’s inhibitory effect on the canonical Wnt pathway, and hence promotes 
osteogenesis [49]. This mechanistic approach adds further evidence to the role of canonical 
Wnt signalling in promoting osteogenic differentiation. All these studies indicate the 
extensive crosstalk contributed by the Wnt signallig network during osteogenic 
differentiation, which should be considered when devising possible new therapeutic 
interventions for bone-related diseases. Moreover, th  available evidence reinforces the 
reciprocal relationship that exists between bone and f t development in response to an 
activated canonical Wnt pathway. 
2.3. Role of Wnt signalling in chondrogenic differentiation 
Wnt signalling is one among the main regulators of chondrogenesis. The promoting role of 
Wnt signalling in chondrogenesis has been demonstrated by a study showing that sFRP1-
deficient mice demonstrated enhanced chondrocyte mauration in both in vivo and in vitro 
conditions [61]. A functional role for Wnt5a, a non-canonical Wnt ligand, in the 
chondrogenesis of MSCs derived from the chicken wing bud has also been demonstrated 
[62]. The level of Wnt5a was up-regulated after trea ment with transforming growth factor β 
(TGFβ), which promoted chondrogenesis. This was further supported by the upregulated pre-
cartilage condensation and chondrogenesis in in vitro micromass cultures in MSCs 
transfected with Wnt5a [62]. The mode of action underlying this could be the blunting of 
canonical Wnt signalling by the non-canonical Wnt ligand Wnt5a, and hence promoting 
chondrogenesis. An increased expression of Wnt3a was associated with the chondrogenic 
differentiation of high density C3H10T1/2 murine mesenchymal cells [63], and the 
overexpression of Wnt3a was also demonstrated to promote this process in the same cell line 
[64]. 
On the other hand, it has been reported that continuous treatment with Wnt1 protein for 21 
days reduced the expression of chondrogenic-specific markers, while treatment with the Wnt 
antagonist Dkk1 increased the expression of chondrogenic markers such as collagen II, Sox9, 
and aggrecan in human adipose-derived MSCs [65]. These results are corroborated by studies 
demonstrating that both sFRP1 and Dkk1 enhanced glycosaminoglycan synthesis, Sox9, and 
type II collagen expression in early chondrogenesis of human MSCs [66], and these Wnt 
antagonists also exhibited a chondrogenesis-promoting effect in long-term pellet cultures 
[67]. 
2.4. Role of Wnt signalling in cardiogenic differentiation 
Previous studies in chick and frog embryos demonstrated that Wnt antagonism induced 
cardiac development while an activated canonical signalling pathway inhibited the 
differentiation [68, 69]. Later, it was found that stimulation of canonical Wnt signalling (by 
use of LiCl) increased the bioavailability of β-catenin, and hence improved myogenic 
differentiation in MSCs derived from aged cardiac ptients [70]. The non-canonical Wnt 













ligand, Wnt11, promoted cardiomyocyte differentiation n MSCs transduced with Wnt11 by 
upregulating GATA-4. The authors postulated that the mechanism involved Wnt11-mediated 
activation of the non-canonical PKC or JNK pathway [71]. Contrastingly, MSCs 
overexpressing sFRP2 have been shown to have reduced apoptosis rates and improved 
engraftment and cardiac function in mice [72]. Exogenous addition of sFRP2 inhibited type I 
procollagen maturation, which is important in scar formation post-myocardial infarction [73], 
and therapeutic concentrations of sFRP2 significantly reduced fibrosis and improved cardiac 
function in rats [73]. However, in another study, a reduced infarct size was observed in 
sFRP2 null mice, thus the authors referred to the known biphasic effect of sFRP2 to explain 
their findings [74]. Overall, an activated Wnt signalling pathway contributes to enhanced 
cardiogenic differentiation in MSCs and this phenomenon should be considered when 
devising MSC-based therapies for myocardial infarction. 
2.5. Wnt signalling inhibits hepatogenic differentiation 
The Wnt pathway has been demonstrated to work synergistically with the MAP/ERK 
signalling pathway to support hepatic progenitor cell proliferation [75]. A study on hepatic 
progenitor cells of the mouse embryo demonstrated that inhibition of Wnt signalling 
(accomplished using the Wnt antagonist sFRP3) prevent d the differentiation of progenitor 
cells into the hepatic lineage [76]. 
Hepatic differentiation in the mouse has been shown to be tightly regulated, with the distinct 
expression of Wnt antagonists such as sFRPs and Dkks in embryonic liver tissues [76]. In 
humans, hepatic differentiation is differentially regulated by the Wnt signalling pathway, 
depending on the stem cell source. Wnt signalling was shown to be down-regulated during 
the hepatic differentiation of adipose tissue-derived MSCs (ADSCs), while it was activated in 
human embryonic stem cells (hESCs) [77]. The distinct response seen in hESCs was also 
observed when Wnt3a pre-treatment facilitated the diff rentiation of hESCs towards hepatic 
endoderm [78]. 
Similar to the effect seen on ADSCs [77], during hepatic differentiation of umbilical cord 
tissue-derived MSCs, there was a downregulation of canonical Wnt signalling. Hence, 
suppression of Wnt signalling in turn promoted hepatic differentiation [79]. It has also been 
demonstrated that application of Frizzled 8 siRNA on MSCs, in which Wnt signalling was 
reduced, resulting in enhanced hepatic differentiation in human bone marrow-derived MSCs 
[80]. Overall, these studies indicate that enhanced hepatic differentiation is observed in 
human MSCs following down-regulation of Wnt signalling. 
2.6. Wnt signalling promotes myogenic differentiation 
The effect of different Wnt molecules on myogenic differentiation has been well documented 
in embryonic development. In MSCs, the Wnt molecules- Wnt1, Wnt3, Wnt7a, Wnt7b, 
Wnt4, and Wnt11 had a promoting effect on gene expression of at least one myogenic 
marker. Among these Wnt proteins, Wnt11 was the most p tent activating factor 
demonstrating gene expression of all myogenic factors-Myf5, MyoD, myogenin, and 
myogenin regulating factor (Mrf4) [81]. The promoting effect of Wnt3a in myogenic 
differentiation has also been reported in rat bone marrow MSCs [82]. The GSK-3β inhibition 
by LiCl and consequent Wnt activation resulted in an increased bioavailability of β-catenin 
and enhanced the myogenic differentiation potential in ged MSCs [70]. Another study 
demonstrated that hypoxia-preconditioned MSCs possessed better engraftment potential into 
ischaemic tissue, and improved skeletal and vascular muscle regeneration when compared to 
normal MSCs. They found that this enhanced effect was brought about by a Wnt4-dependent 
pathway, and that hypoxia-preconditioned MSCs had an increased number of Wnt4 
transcripts in the ischaemic area compared to the normal MSCs [83]. Altogether, it suggests 
that activated Wnt signalling enhances the myogenic differentiation potential of MSCs. 
2.7. Wnt signalling positively influences neurogenic differentiation 













It has been demonstrated that Wnt3a protein promotes the differentiation of neural stem cells 
into neuronal lineages while inhibiting their self-renewal [84]. In cortical mouse neural 
precursor cells, Wnt7a also enhanced neuronal differentiation [85]. Further, in MSCs, the 
activating role of canonical Wnt signalling has been d termined using specific neuronal 
markers such as neuron-specific enolase and nestin. These markers were up-regulated when 
Wnt signalling was activated using Wnt3a and down-regulated when Wnt signalling was 
blocked by siRNA for β-catenin [86]. It was also found that Wnt7a enhanced n uronal 
differentiation in human MSCs via both canonical and non-canonical signalling pathways 
[87]. Further, the Wnt antagonists Dkk1 and sFRP4 reversed Wnt7a’s promoting effect [87]. 
Re-activation of the Wnt signalling pathway reversed the age-related decline in neurogenic 
differentiation in MSCs derived from dental pulp [88]. Further investigation into the 
mechanism of Wnt-induced up-regulation of neurogenic differentiation in MSCs has revealed 
the role of T-cell leukaemia 3 (Tlx3) in interacting with the TCF3/4 of the canonical Wnt 
signalling pathway. In this study, it was shown that Wnt1 upregulates Tlx3, and a forced 
expression of Tlx3 improved neurogenic differentiation [89]. Wnt5a promoted neurogenic 
differentiation in human ADSCs, binding to Fz3 and Fz5, and signalling through the Wnt5a-
JNK pathway [90]. In summary, activation of Wnt signalling plays a key role in promoting 
the differentiation of MSCs towards a neuronal fate. 
The overall impact exerted by the activation of the Wnt signalling pathway on the 
differentiation of human MSCs has been schematically represented in Fig. 1. 
 
3. Link between wnt/β-catenin signalling and reactive oxygen species 
Recent findings have demonstrated that there is a close association between reactive oxygen 
species (ROS) and activation of the Wnt/β-catenin pathway. β-catenin is translocated to the 
nucleus after the inhibition of the protein complex comprised of Axin, APC, GSK-3β, and 
CK1α [91]. This inhibition is assisted by Dishevelled (Dvl), a protein present in the 
cytoplasm, which inhibits GSK-3β-mediated phosphorylation of β-catenin, allowing its 
translocation [92]. Dvl and a thioredoxin-like protein, nucleoredoxin (NRX), have been 
shown to directly interact and inhibit Wnt/β-catenin signalling and this association is 
attenuated by hydrogen peroxide (H2O2), suggesting that Wnt/β-catenin signalling may be 
modulated by oxidative stress [93]. Wnt signalling s carefully balanced by the competition 
between NRX and a Kelch-like 12 (KLHL12) protein, both associated with the PDZ-domain 
of Dvl. In the absence of a Wnt ligand, the binding of NRX to Dvl promotes the inactive state 
of Dvl, thereby preventing aberrant activation of the pathway until a sufficient Wnt stimulus 
occurs. Upon Wnt binding, Dvl frees itself from NRX, activates downstream signalling, and 
is then ubiquitylated by KLHL12, thus preventing persistent activation of the Wnt signalling 
pathway [94]. Recently it was also demonstrated that inhibition of Ca2+-mediated ROS 
production from the mitochondria attenuated the Dvl/NRX association, which led to a 
decrease in Wnt/β-catenin activation and inhibited the ability of neuronal cells to differentiate 
in vitro [95]. Although a full understanding of ROS activation of the Wnt/β-catenin pathway 
has yet to be elucidated, it is known that Wnt antagonists also play a role in the modulation of 
ROS. It has been shown that sFRP4 can increase superoxide and H2O2 levels while 
decreasing catalase activity in endothelial cells, and thus inhibiting angiogenesis [25]. Further 
research into the mechanisms of ROS activation of the Wnt/β-catenin pathway has the 
potential to provide possible treatment options for many Wnt-associated diseases. 
3.1. The source and generation of reactive oxygen species 
There are many potential sources of ROS within the cell; the primary source of ROS is from 
the mitochondria where free-radical superoxide anion (O2
-) is generated via the electron 
transport chain, primarily from complex I [96] and III by single electron reduction of 
molecular oxygen [97]. Superoxide (O2
-) is converted to H2O2 (which has a much longer half-













life) through ROS scavengers such as superoxide dismutase (SOD) in the cytosol 
(SOD1/CuZn-SOD), mitochondrial matrix (SOD2/MnSOD), and in extracellular 
compartments (SOD3) [98]. 
Another important source of ROS is from the nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase complexes, which together are known as NOX enzymes [99]. Oxygen is 
converted to superoxide through pyridine nucleotide-mediated reduction by NOX enzymes at 
specific membrane-associated sites [100], thus generati g superoxide for release into 
phagolysosomes (in phagocytic immune cells) and either cytosolic or extracellular release. 
The superoxide anion can also react with nitric oxide (NO) to form peroxynitrite (ONOO-) 
[101], which has been shown to induce apoptosis through caspase activation [102].  
Hydrogen peroxide is classed as a reactive oxidising chemical that can be converted to water 
and oxygen in the peroxisome and cytosol through enzymatic action by catalase. 
Furthermore, it is reduced to H2O through the enzymatic action of antioxidant glutathione 
peroxidases (GPx), which catalyse the reaction 2GSH + H2O2 →GSSG + 2H2O and by 
peroxiredoxins (Prxs) in the cytosol, Prxs (reduced) + H2O2→ Prx (oxidised) + 2H2O [103]. 
Other intracellular sources of ROS include the endoplasmic reticulum as well as other 
enzyme systems such as xanthine oxidase, lipoxygenase, cyclooxygenase, cytochrome P450, 
and monooxygenase [99]. ROS, together with the peroxisomes and mitochondria, serve many 
functions including cellular proliferation [104], migration [105], differentiation [100], 
survival [106-108], and cell signalling [109]. ROS play a crucial role in cellular homeostasis 
and a variety of processes within all cell types. Interestingly, the study of ROS within MSCs 
has gathered pace recently due to its complex nature, the involvement of a variety of cell 
signalling pathways, including Wnt, a myriad of protein interactions, and its involvement in 
mesenchymal differentiation. 
3.2. Mesenchymal stem cells and reactive oxygen species 
MSCs exhibit relatively low levels of ROS, possibly due to their increased levels of 
glutathione, SOD1/SOD2, catalase, and GPx [110]. It has also been shown that varying levels 
of ROS control different signalling pathways within MSCs, which are responsible for many 
cellular functions and cellular differentiation. These pathways include Wnt, Forkhead box 
(FOXO), Hedgehog [111], Nel-like protein 1 (NELL-1), insulin-like growth factor (IGF), and 
bone morphogenetic protein (BMP). Various, highly defined levels of ROS activate these 
aforementioned signalling pathways to regulate MSC differentiation into chondrocytes [112], 
adipocytes [113], and osteocytes [114]. Although the role of redox regulation in MSCs has 
yet to be fully elucidated, other stem cells such as h ematopoietic stem cells and progenitor 
cells have been described in terms of stem cell development, function, and survival in this 
regard [115]. In this review we have aimed to comprehensively summarise the redox 
regulation of MSC differentiation.  
 
4. Reactive oxygen species-mediated differentiation of mesenchymal stem cells 
4.1. Adipogenic differentiation 
MSCs differentiate to an adipogenic lineage through the activation of several transcription 
factors including CCAAT/enhancer binding protein (C/EBP)β, which induces C/EBPα and 
PPARγ [116]. It has now been shown that adipogenic differentiation may be mediated by 
NADPH oxidase 4 (Nox4) via the cAMP response element-bi ding protein (CREB) [113]. It 
has been shown that CREB over-expression in pre-adipocytes promotes the expression of 
C/EBPα and RXRα [117]; while concurrently, it has been demonstrated that antioxidants 
such as N-acetylcysteine (NAC) or apocyanin will suppress CREB [113]. There is further 
evidence for ROS-mediated adipogenic differentiation in MSCs by Prx1 over-expression 
inhibiting lipid accumulation, as well as antioxidant (NAC) inhibition of C/EBPα and PPARγ 
[113]. Superoxide generating complex III has also been implicated in the transcriptional 













activation of PPARγ [118], while H2O2 increases adipogenesis [119] and diminishes the 
expression of adipo-cytokines [100]. This evidence suggests that increasing intracellular 
levels of ROS are involved in signalling cascades responsible for the differentiation of MSCs 
into adipocytes. 
4.2. Osteogenic differentiation 
There have been numerous signalling pathways implicated in osteogenic differentiation in 
MSCs including Wnt, FOXO, and Hedgehog; all of which have been shown to be suppressed 
by high levels of ROS [100]. The Wnt signalling pathway is a positive regulator of 
osteogenesis through the translocation of β-catenin into the nucleus, where it binds TCF/LEF, 
allowing the activation of Wnt target genes such as Axin2 as well as increasing the expression 
of Run2x, Dlx5, and Osterix, which are critical osteogenic transcription factors [120]. Wnt 
signalling has been shown to decrease the expression of C/EBPα and PPARγ, and thus 
favours osteogenesis rather than adipogenesis [31]; although high levels of ROS, specifically 
H2O2 (which has been shown to inhibit Wnt/β-catenin signalling), would then promote a 
more favourable adipogenic environment [121]. 
The FOXO signalling pathway is also mediated by ROS, where high levels induce 
phosphorylation and drive its translocation into the nucleus where it is activated. FOXO has 
been shown to suppress osteogenic differentiation [122] while concurrently promoting 
adipocyte differentiation [123]. Increased levels of H2O2 stimulate FOXO transcription, 
although it also promotes the association of FOXO with β-catenin, which leads to an 
inhibition of Wnt target genes essential for osteogenic differentiation [124]. Overall, higher 
levels of oxidative stress antagonize the Wnt/β-catenin p thway, leading to attenuation of 
osteogenesis while stimulating FOXO-mediated adipogenic differentiation. It is noteworthy 
that a shift to adipogenic lineage in MSCs has been r ported in patients with osteoporosis.  
This has been linked to the increased expression of the histone H3 methylating protein 
Enhancer of Zeste homology 2 (EZH2) which silences th  Wnt genes, and hence 
pharmacological inhibition of EZH2 with 3-deazaneplanocin A (DZNep) reverted the cells to 
osteogenic lineage [125]. These data argue in favour of targeting EZH2 as a potential strategy 
against osteoporosis. Alternatively, the use of anti-oxidants, such as N-acetyl cysteine 
(NAC), or SOD mimetics might also serve to tailor the redox environment for osteogenic 
differentiation. 
The interaction between ROS (in the form of H2O2) and the Wnt signalling pathway, and the 
resultant effect on MSC differentiation into adipocytes and osteoblasts is demonstrated in 
Fig. 2.  
4.3. Chondrogenic differentiation 
Recent studies have demonstrated that ROS is required fo  chondrogenic differentiation, 
primarily through NADPH oxidase 2 and 4 (Nox2 and Nox4) [112]. This was demonstrated 
by inhibition of chondrogenic differentiation gene markers Sox9, Col2a1, and Col10a1 by the 
introduction of the ROS scavenger NAC; and so, provide proof that ROS is necessary for 
chondrogenic differentiation [112]. Although less i known in regards to chondrogenic 
differentiation mediated by ROS in MSCs, this is an attractive area of study and may have 
wider implications in the field of regenerative medicine. 
 
5. Conclusions 
In this review we have exemplified the differential impact that Wnt signalling exerts on MSC 
differentiation pathways. Summarising the broad spectrum of the influence of Wnt signalling 
on MSC differentiation, we have shown that the outcmes of activated Wnt are inhibition of 
adipogenic and hepatogenic differentiation. On the other hand, a different outcome of 
activated Wnt signalling favours neurogenic and myogenic differentiation. Wnt signalling 
exerts mixed effects on osteogenic, chondrogenic, ad c rdiogenic differentiation, where it 













can either promote or inhibit the process; and this could be dependent on many factors such 
as cell type and interaction with other signal transduction pathways, etc. The exact 
mechanism underlying the molecular regulation of differentiation processes remains to be 
unravelled.  
The role of ROS in MSC differentiation has also yet to be completely elucidated, although 
research has shown that the level of H2O2 tends to favour differentiation into adipocytes, 
chondrocytes, or osteocytes. ROS-mediated differentiation into the other possible MSC 
lineages such as neuronal cells, hepatocytes, and myocytes has yet to be investigated in 
detail. MSC differentiation occurs through the interplay of different pathways including the 
FOXO and Wnt/β-catenin signalling pathways. It has been demonstrated that these pathways 
can regulate ROS levels, and concomitantly ROS levels can influence the activity of these 
pathways. ROS signalling has been implicated in osteogenic differentiation, where high 
levels of H2O2 inhibit Wnt/β-catenin signalling and favour osteogenesis, and low levels of 
H2O2 activate Wnt/β-catenin signalling to promote adipogenesis. Further studies into the 
mechanisms of ROS-mediated differentiation are important for a complete understanding of 
MSC differentiation. 
MSCs have gained a lot of clinical interest, considering their potential for various tissue 
engineering and reconstructive surgery applications, due to their extensive self-renewal and 
multipotent differentiation capabilities. Hence them chanism underlying these differentiation 
processes, tightly regulated by signal transduction networks such as the Wnt signalling 
pathway and ROS, needs to be further examined. A profound knowledge about these 
processes will in turn aid in the development of novel strategies in regenerative medicine. 
Recent evidence points to a critical role of tissue hypoxia on the proliferation and 
differentiation of multipotent MSCs [126,127]. To that end, manipulation of the cellular 
redox milieu could have potential therapeutic implicat ons, whereby the use of anti-oxidants 
could serve to switch MSCs from adipogenic to osteogenic differentiation; however, if the 
desired outcome is to obtain adipogenic differentiation, one could be tempted to employ 
agonists of the nuclear PPARγ receptor. Furthermore, hypoxia was shown to enhance MSC 
viability and proliferation as well as differentiation into adipocytes and osteocytes [127], 
which could have potential implications in regenerative medicine. 
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Fig. 1 Schematic illustration of the effect of Wnt signalling on the various MSC 
differentiation pathways. 
Fig. 2 Schematic demonstrating the effect of ROS (depicted here as H2O2) in blocking Wnt/β-
catenin signalling and promoting differentiation of MSCs into adipocytes and osteoblasts. 
 
 
 
